Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-12-19
1991-07-09
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514825, 514824, A61K 31395, C07D20508, C07F 9568, C07F 718
Patent
active
050306286
ABSTRACT:
The invention relates to N-aryl-azetidinones, their preparation process and their use as active serine elastase inhibitors.
The N-aryl-azetidinones are in accordance with formula: ##STR1## in which R.sup.1 and R.sup.2 can be a halogen atom or an organic radical, R.sup.3 represents a halogen atom or another good starting group and R.sup.4 represents H or an organic radical.
The compounds with R.sup.3 .dbd.Cl or OSO.sub.2 CH.sub.3, R.sup.4 .dbd.H and R.sup.1 .dbd.R.sup.2 .dbd.F or R.sup.1 .dbd.F and R.sup.2 .dbd.Br are irreversible and selective elastase inhibitors.
REFERENCES:
patent: 4680391 (1987-07-01), Firestone
patent: 4803266 (1989-02-01), Kawash
Stirling, Ed, "The Chemistry of the Sulphonium Group", pp. 269, 267 (1981).
Zrihen, European Journal of Medicinal Chemistry, vol. 18, No. 4, 1983, pp. 307-314.
Ongania, Zeitschrift Fur Naturforschung, vol. 49b, No. 1, part B, Jan. 1985, pp. 115-116.
Joyeau Roger
Kobaiter Randa
Reboud Michele
Wakselman Michel
Berch Mark L.
Scientifique
LandOfFree
N-aryl-azetidinones, their preparation process and their use as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-aryl-azetidinones, their preparation process and their use as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aryl-azetidinones, their preparation process and their use as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618336